The BioWorld Biotechnology State of the Industry Report 1999 ¿ the most comprehensive update on the business and science of biotechnology, as well as government regulation of it ¿ is now available.

At 338 pages, the report details the industry¿s progress last year, when ¿selectivity¿ was the watchword in financings and a tight money market prevailed. Mergers and acquisitions picked up steam, as companies partnered to gain better positions in an increasingly competitive world.

The report examines biotechnology from Wall Street, the lab bench and Washington. It tracks stock performance, product development and FDA actions in a comprehensive, easy-to-read format that provides the most reliable information available.

Available now, the BioWorld Biotechnology State of the Industry Report 1999 looks back and looks ahead, to past trends and the movements in the industry that are likely to continue. To purchase a copy, call (800) 688-2421.